Food and Drug Administration, HHS.
Notice; extension of comment period.
The Food and Drug Administration (FDA) is extending the comment period to November 30, 2011, for the notice entitled, “Burden of Food and Drug Administration Food Safety Modernization Act Fee Amounts on Small Business; Request for Comments” that appeared in the Federal Register of August 1, 2011 (76 FR 45818). In that document, FDA announced the establishment of a docket to obtain information that would be used to formulate a proposed set of guidelines in consideration of the burden of fee amounts on small business, as set forth in the FDA Food Safety Modernization Act (FSMA). In particular, the Agency requested public comments on whether a reduction of fees or other consideration for small business was appropriate, and if so, what factors the Agency should consider for each. In addition, the Agency requested public comment on how small business should be defined or recognized. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.
Submit either electronic or written or comments by November 30, 2011.
Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Alexis Nazario-Negron, Office of Financial Management, Food and Drug Administration, 1350 Piccard Dr., Rm. 210E, Rockville, MD 20850, 301-796-7223, Alexis.Nazario-Negron@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
In the Federal Register of August 1, 2011 (76 FR 45818), FDA published a notice with a 78-day comment period to request comments on the burden of FSMA fee amounts on small business. FSMA provides the Agency with authority under section 743 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) to assess and collect fees, including those for costs associated with certain domestic and foreign facility reinspections, failure to comply with a recall order, and importer reinspections. The Agency is seeking public comment on what burdens these fees might impose on small business, and whether and how the Agency should alleviate such burdens. In particular, the Agency is seeking public comments on whether a reduction of fees or other consideration for small business is appropriate, and if so, what factors the Agency should consider for each. In addition, the Agency is seeking public comment on how small business should be defined or recognized. The Agency has received a request for an extension of the comment period. The request conveyed concern that the current 78-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the notice.
FDA has considered the request and is extending the comment period for the notice until November 30, 2011. The Agency believes that this extension allows adequate time for interested persons to submit comments without significantly delaying the development of a proposed set of guidelines in consideration of the burden of the fee amounts on small business, as required by section 743(b)(2)(B)(iii) of the FD&C Act.
II. Request for Comments
Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments on this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.Start Signature
Dated: October 12, 2011.
Acting Associate Commissioner for Policy and Planning.
[FR Doc. 2011-26815 Filed 10-17-11; 8:45 am]
BILLING CODE 4160-01-P